In more recent times the US in particular has started spending big on Rapid Antigen Tests. So it was interesting to see the 4C mention the possibility of US based manufacturing as well to increase production capacity.
Here is an article from yesterday re a National Cabinet discussion on planning for RAT in places like schools, day care, aged care & hospitals.
Whilst there is a lot of competition there is still plenty of opportunity for RNO. As others have mentioned, hopefully news on the Junior trials isn't too far away.
cheers
RNO Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held